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Many pathogenic microbes, including many fungi, produce phospholipases which facilitate 
survival of the pathogen in vivo, invasion and dissemination throughout the host, expression 
of virulence traits and evasion of host immune defense mechanisms. These phospholipases 
are either secreted or produced intracellularly and act by physically disrupting host membranes, 
and/or by affecting fungal cell signaling and production of immunomodulatory effectors. 
Many of the secreted phospholipases acquire a glycosylphosphatidylinositol sorting motif to 
facilitate membrane and/or cell wall association and secretion. This review focuses primarily 
on the role of two members of the phospholipase enzyme family, phospholipase B (Plb) and 
phosphatidylinositol (PI)-specific phospholipase C (PI-C/Plc), in fungal pathogenesis and in 
particular, what has been learnt about their function from studies performed in the model 
pathogenic yeast, Cryptococcus neoformans. These studies have revealed how Plb has adapted 
to become an important part of the virulence repertoire of pathogenic fungi and how its secretion 
is regulated. They have also provided valuable insight into how the intracellular enzyme, Plc1, 
contributes to fungal fitness and pathogenicity – via a putative role in signal transduction 
pathways that regulate the production of stress-protecting pigments, polysaccharide capsule, 
cell wall integrity, and adaptation to growth at host temperature. Finally, this review will address 
the role fungal phospholipases have played in the development of a new class of antifungal 
drugs, which mimic their phospholipid substrates.
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remove the polar head group from PI, which can be present as 
either mono- or diphosphorylated inositol or as the glycosylphos-
phatydylinositol (GPI) anchor on some membrane and cell wall 
proteins, including fungal Plbs (Figure 1). Both Plb and PI-PLC 
can be secreted or remain intracellular. Many Plb enzymes have a 
GPI anchor which provides an additional level of secretory regula-
tion and appears to serve as a sorting signal for efficient cellular 
export of fungal Plbs. The lipid derived products of Plb and PI-PLC 
may act as secondary messengers in signal transduction, or exert 
immunomodulatory effects.
CryptoCoCCus neoformans – an effective model 
fungal pathogen for characterizing phospholipase 
virulence determinants
The basidiomycetous fungal pathogen, Cryptococcus neoformans, 
has a predilection to cause infection in patients with AIDS and 
is responsible for an estimated one million cases of meningitis 
and 675,000 deaths per year in HIV-infected patients alone (Park 
et al., 2009). Infections also occur in immunocompetent indi-
viduals (Chau et al., 2010). The other pathogenic Cryptococcus 
species, C. gattii, mainly infects immunocompetent individuals 
and was responsible for an outbreak of cryptococcosis that was 
first noted in 1999 on Vancouver Island, British Columbia (BC), 
Canada (Ma et al., 2007). There are two varieties of C. neoformans, 
C. neoformans var. grubii (Serotype A) and C. neoformans var. 
the phospholipase enzyme family and the activities 
of fungal plb and plc
Phospholipases are a heterogeneous group of enzymes that hydro-
lyse one or more ester linkages in glycerophospholipids (Figure 1), 
which are the major components of cell membranes and lung sur-
factant. Each glycerophospholipid consists of a glycerol backbone 
containing one (lysophospholipid) or two (phospholipid) ester 
linkages to hydrophobic fatty acid chains, and a third ester linkage 
to a phosphate head group. The phosphate head group is also linked 
by an ester bond to a variety of polar moieties, such as choline, 
ethanolamine, serine, and inositol. Phospholipases are categorized 





 B, C, and D (Figure 1). Two major phospholipases associated 
with pathogenicity in fungi are phospholipase B (Plb) and phos-
phatidylinositol (PI)-preferring phospholipase C (PI-PLC/Plc). Plb 
enzymes remove both fatty acyl chains from glycerophospholipids. 
They may also have lysophospholipase (LPL) and lysophospholi-
pase-transacylase (LPTA) activities, both of which can contribute 
to the detoxification of potentially cellulolytic lysophospholipids. 
Specifically, the LPL activity removes the single fatty acyl chain 
on a lysophospholipid to produce glycerophosphocholine (GPC) 
and the LPTA activity re-esterifies an acyl chain onto a lysophos-
pholipid, thus regenerating a glycerophospholipid (Figure 2). It 





) and LPL activities. PI-PLCs (or Plcs) 
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phospholipase b enzymes implicated in fungal 
virulence
It is well-established through gene deletion and reconstitution 
experiments that phospholipases contribute to the virulence rep-
ertoire of pathogenic fungi, despite their presence in the mainly 
non-pathogenic and industrial yeasts. Pathogenic fungi that 
secrete phospholipase B include C. neoformans (Chen et al., 1997b; 
Santangelo et al., 1999), Candida albicans (Ibrahim et al., 1995; 
Mirbod et al., 1995; Theiss et al., 2006), and Aspergillus fumigatus 
(Shen et al., 2004). The most well characterized phospholipase B 
enzymes produced by fungal pathogens are phospholipase B 1, 2, 
and 5 from C. albicans (Sugiyama et al., 1999; Mukherjee et al., 
2001; Theiss et al., 2006) and phospholipase B1 from C. neoformans 
(Chen et al., 2000) and Cryptococcus gattii (Wright et al., 2004) 
(CaPlb1/2/5, CnPlb1, CgPlb1, respectively). Only CaPlb2 does 
not play a significant role in virulence while the role of CgPlb1 
in virulence has not been assessed. CnPlb1, CaPlb1, and CgPlb1 
all possess PLB, LPL and LPTA enzymatic activities, with proper-
ties that differ to each other and to Plb1 homologs produced by 
industrial yeasts (Takahashi et al., 1991; Mirbod et al., 1995; Chen 
et al., 2000).
The C. neoformans genome contains a single PLB gene, PLB1, 
with an established role in virulence (Cox et al., 2001). In addi-
tion to CnPlb1, C. neoformans produces a Plb1-independent 
phospholipase A1, which degrades 1-palmitoyl-2-arachidonoyl 
phosphatidylcholine. Neither the gene encoding this enzyme, nor 
the protein it specifies, have been isolated (Wright et al., 2007) and 
its role in virulence has not been determined. C. neoformans also 
produces two additional LPL/LPTA enzymes, CnLyso1 and CnLpl1, 
which were characterized in serotype D (Coe et al., 2003) and C. 
gattii (Wright et al., 2004), respectively. The CnLYSO1 found in 
serotype D itself is not predicted to be secreted as it has no secre-
tory leader peptide, but appears to affect the secretion of CnPlb1 
(Coe et al., 2003). Its role in virulence is unknown. Interestingly, 
although CnLpl1 found in serotype A does contain a putative secre-
tory leader peptide, it does not contribute to the pool of secreted 
PLB activity, at least in cultures maintained on agar; this pool was 
attributed solely to CnPlb1 activity (Cox et al., 2001). Disruption 
of the CnLPL1 homolog in serotype A altered neither growth nor 
virulence of C. neoformans in a mouse model (M. Chayakulkeeree, 
and J. T. Djordjevic, unpublished observation). It may function 
in association with CnLyso1 to remove toxic lysophospholipids 
(Wright et al., 2007). These three enzymes may provide functional 
redundancy by maintaining cryptococcal growth in the absence 
of CnPlb1.
The genome of C. albicans encodes a Plb multigene family with 
five putative members. The best studied genes in this family are 
CaPLB1, CaPLB2, and CaPLB5 which encode putative secreted 
proteins (Leidich et al., 1998; Sugiyama et al., 1999; Mukherjee 
et al., 2001; Theiss et al., 2006). Only CaPLB1 and CaPLB5 have 
an established role in virulence (Leidich et al., 1998; Hoover et al., 
1998; Mukherjee et al., 2001; Theiss et al., 2006). Abrogation of 
CaPlb1 and CaPlb5 enzymatic activity by inactivation of CaPLB1 
and CaPLB5, respectively, rendered the mutant strains less virulent 
in systemic mouse models of infection as measured by host tissue 
colonization (Leidich et al., 1998; Mukherjee et al., 2001; Theiss 
et al., 2006). Loss of these genes coincided with reduced LPTA/
neoformans (Serotype D), with serotype A being the more clini-
cally prevalent and virulent serotype (Martinez et al., 2001). The 
predominant natural habitat of C. neoformans is nitrogen-rich 
avian guano, soil and possibly decaying material from trees. It has 
been suggested that its pathogenicity for mammals evolved as a 
consequence of phagocytic interactions with soil ameba (Alvarez 
et al., 2009). In immunocompetent individuals, phagocytosis of 
inhaled spores or small dessicated yeast cells by macrophages 
may result either in clearing of the infection or establishment of 
a latent infection in the lung. However, in the immunocompro-
mised individual there is evidence that macrophages may also 
transport C. neoformans to the central nervous system where it 
establishes severe life-threatening meningoencephalitis (Charlier 
et al., 2009). Not only is C. neoformans an important pathogen 
in its own right, it is also an excellent model for studying fungal 
pathogenesis, as the recently sequenced haploid genomes of both 
serotypes A and D are amenable to a range of genetic manipula-
tion techniques, including targeted gene disruption and RNAi 
and robust animal models of infection are available to assess 
the role of genes in virulence. Much of our knowledge about 
fungal phospholipase enzymatic activities and their contribution 
to pathogenesis has been derived from studies performed on 
cryptococcal enzymes. In fact, C. neoformans is the only fungal 
pathogen in which the effect of absence of the Plc1-encoding 
gene on fungal fitness and pathogenicity has been determined 
(Chayakulkeeree et al., 2008).
FIgure 1 | The phospholipid cleavage sites of phospholipase enzymes. 
The phospholipid glycerol backbone is shown in red. Phospholipase A1 (A1) 
cleaves a fatty acyl ester at the sn1 position while phospholipase A2 (A2) 
removes the fatty acid at the sn2 position to yield a lysophospholipid and a 
fatty acid. Phospholipase B (B) removes both acyl chains from the sn1 and sn2 
positions on the glycerol backbone. The phosphodiester bond in the head 
group proximal to the glycerol backbone is cleaved by phospholipase C (C) to 
yield diacylglycerol and the phosphoryl head group. PI-PLC enzymes perform 
this cleavage when X is inositol, which may, or may not, be linked to 
phosphates or a sugar chain composed predominantly of mannosyl sugars in 
the case of a GPI anchor. Cleavage by phospholipase D (D) at the 
phosphodiester bond proximal to X, yields phosphatidic acid and X, which can 
be either ethanolamine, serine, inositol, or choline. Adapted from the PhD 
thesis of Dr Rosemary A. Siafakas.
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plb homologs in pathogenic fungi differ from those 
in non-pathogenic fungi
PLB genes are present in non-pathogenic yeasts including 
Saccharomyces cerevisiae, Debaryomyces (Torulaspora) hansenii, 
Penicillium notatum, Schizosaccharomyces pombe, Torulaspora del-
brueckii, Neurospora crassa, and Kluyveromyces lactis (reviewed in 
Ghannoum, 2000). Extensive enzymatic characterization of the 
Plb enzymes secreted by the pathogenic yeasts, C. neoformans 
and C. albicans, and a comparison of their properties to the Plb 
PLB and PLA
2
 activity, respectively. Neither the role of CnPlb1 
and CaPlb5 in virulence nor their enzymatic properties have been 
determined. The genome of A. fumigatus encodes three PLB genes 
(Shen et al., 2004). However, their role in virulence has not yet been 
established. It is important to note that not all pathogenic fungi 
secrete significant amounts of Plb. One such example is Candida 
parapsilosis where, due to contradictory findings among various 
investigators, the role of secreted Plb in pathogenesis is unclear 
(Trofa et al., 2008).
FIgure 2 | enzymatic activities of phospholipase B enzymes. 
Phospholipase B (PLB) activity is a combination of PLA1 and PLA2 activities 
(or PLA and LPL activity) and generates glycerophospho compounds. 
Lysophospholipid, a short-lived intermediate, is also a substrate for 
lysophospholipase (LPL) and lysophospholipase-transacylase (LPTA) 
activities, which rapidly hydrolyse or re-esterify lysophospholipid, 
respectively. R1 and R2 represent fatty acid chains in the sn1 and sn2 
position of the phospholipid, respectively. X refers to the head group (e.g., 
serine, ethanolamine, choline, or inositol). Adapted from the PhD thesis of Dr 
Rosemary A. Siafakas.
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transported to the surface and subsequently secreted. Both CnPlb1 
and CaPlb1 have been detected in fungal secretions and within host 
tissue. In the case of CnPlb1, secretion still occurs despite the acqui-
sition a glycosylphosphatidylinositol (GPI) anchor which permits 
CnPlb1 association with membranes and the cell wall, suggesting 
that CnPlb1 must be released from the anchor prior to secretion. 
In contrast to CnPlb1, CaPlb1, and CaPlb2 do not acquire a GPI 
anchor, while CaPlb5 (and CaPlb3, CaPlb4) are predicted to acquire 
one (Theiss et al., 2006). Of the Plbs produced by A. fumigatus, 
AfPlb2, is the only Plb not predicted to be secreted or GPI anchored. 
It is not known why some Plbs involved in virulence acquire a 
GPI anchor and some do not. However, in addition to permitting 
membrane and cell wall localization, the anchor in CnPlb1 appears 
to play a role in regulating CnPlb1 export and secretion.
GPI anchors and rafts. Following export through the secretory 
pathway to the cell periphery, some fungal GPI-anchored proteins 
are retained at the plasma membrane while others are released from 
it by an undefined cleavage mechanism within the GPI anchor (Lu 
et al., 1994; Kollar et al., 1997; Fujii et al., 1999; Gagnon-Arsenault 
et al., 2008). Cleavage allows the GPI-anchored protein to be trans-
ported to the cell wall and covalently cross-linked to β-1,6-glucans 
via the GPI anchor remnant (Kapteyn et al., 1994; Lu et al., 1994) 
or secreted. The means by which fungal GPI-anchored proteins 
are differentially targeted to the membrane or cell wall are poorly 
understood. However, the signals reside in the C-terminus (Mao 
et al., 2008). We have found CnPlb1 to be associated with both 
membranes and the cell wall fraction (Siafakas et al., 2006; Siafakas 
et al., 2007).
In fungi, GPI-anchored proteins cluster within sphingolipid/
sterol-rich microdomains, or rafts, within the plasma membrane 
(Muniz and Riezman, 2000; Insenser et al., 2006). We also demon-
strated that treatment of cryptococci with the raft disrupting agent, 
methyl-β-cyclodextrin, which binds to sterols, releases CnPlb1 pro-
tein and enzyme activity into the external milieu, consistent with 
CnPlb1 also localizing within plasma membrane rafts following its 
transport to the cell periphery (Siafakas et al., 2006). We also found 
that CnPlb1-containing membranes are enriched in sterols, insolu-
ble in Triton X-100 at 4°C and of a higher buoyant density than 
Triton X-100-soluble membranes (Siafakas et al., 2006), consistent 
with the properties of rafts (Bagnat et al., 2000). We proposed that 
raft membranes serve to cluster CnPlb1 at the cell surface to allow 
efficient access to enzyme substrate and/or to provide a mechanism 
for rapid release to the external environment (Siafakas et al., 2006). 
However, since both raft assembly and the sorting of GPI anchored 
proteins into raft-enriched secretory vesicles occurs within the ER 
(Sutterlin et al., 1997; Bagnat et al., 2000; Muniz and Riezman, 
2000), the association of CnPlb1 with cryptococcal rafts may also 
be an early secretory event.
GPI anchors are also essential for export of CnPlb1 to the 
periphery as CnPlb1 export is blocked when GPI anchor synthesis 
is blocked (Siafakas et al., 2007). In addition, deletion of the GPI 
anchor consensus motif, which serves as a temporary ER reten-
tion signal until fully synthesized GPI anchors are substituted for 
it, resulted in a higher ratio of secreted to cell-associated CnPlb1 
in a heterologous S. cerevisiae expression system due to the lack of 
CnPlb1 retention in the membrane and cell wall (Djordjevic et al., 
homologs produced by non-pathogenic yeasts, has revealed why 
these enzymes are more adapted to a role in virulence (Chen 
et al., 2000). Firstly, the specific activities of purified cryptococcal 
and candidal Plb1 enzymes are 10- to 200-fold higher than the 
corresponding homologs from non-pathogenic fungi (Lee et al., 
1994; Mirbod et al., 1995; Merkel et al., 1999; Chen et al., 2000). 
Secondly, the major membrane phospholipids, dipalmityolphos-
phatidylcholine (DPPC) and phosphatidylglycerol, which are also 
the most abundant components of lung surfactant, and lysophos-
phatidylcholine, are preferred substrates of CnPlb1, whereas the 
less accessible, acidic inner-leaflet phospholipids, phosphatidyl-
serine, phosphatidylinositol, and phosphatidic acid are preferred 
substrates of Plbs from non-pathogenic fungi (Witt et al., 1984; 
Saito et al., 1991; Oishi et al., 1996; Merkel et al., 1999). This 
observation suggests that Plb1 secreted by pathogenic fungi is 
more likely to digest host cell membranes and surfactant than Plb1 
secreted by non-fungal pathogens. In support of this, the extent 
of cell damage caused by culture supernatants prepared from C. 
albicans (62%) was less than that caused by the CaPLB1-deficient 
strain and S. cerevisiae (35 and 4%, respectively) as assessed using 
a thiazolium blue-based assay (Ghannoum, 2000). Thirdly, a 
range of protein modifying agents differentially affect the activi-
ties of CnPlb1, Plb homologs from non-pathogenic fungi and 
mammalian secretory PLA2 (Chen et al., 2000). The millimolar 
quantities of acetic acid secreted by C. neoformans in vitro (Bubb 
et al., 1999) and in experimental lung and brain cryptococcomas 
(Himmelreich et al., 2003) may create a microenvironment favo-
rable for CnPlb1, which has an acidic pH optimum (Chen et al., 
2000). As C. neoformans is well-adapted to intracellular survival 
in the acidified phagolysosome (pH 5.0) of human macrophages 
(Levitz et al., 1999), secreted CnPlb1 may be a contributing sur-
vival factor.
evidence for production of fungal plb in vivo
There is evidence to suggest that Plb1 produced by pathogenic fungi 
is also produced during infection in vivo. CaPlb1 was identified 
immunologically in host tissue (Ghannoum, 2000; Mukherjee et al., 
2001) and the GPC product of CnPlb1 is present in lung and brain 
cryptococcomas produced in a rat model (Himmelreich et al., 2003; 
Sorrell et al., 2006). Furthermore, antibodies to CaPlb1 and CnPlb1 
have been identified in the serum of infected patients (Ghannoum, 
2000; Santangelo et al., 2005). In addition, blood isolates of C. albi-
cans generally secrete much higher levels of CaPlb1 than isolates 
from the oral cavity of healthy individuals (Ibrahim et al., 1995) 
or isolates from wounds or urine (Price et al., 1982).
factors regulating cnplb1 cellular export to the 
periphery and secretion
Cryptococcal and candidal Plbs with an established role in virulence 
(CnPlb1, CaPlb1, CaPlb2, and CaPlb5) contain a secretory leader 
peptide at the N-terminus and we have confirmed that deletion of 
this motif in CnPlb1 abolishes its secretion within a heterologous 
expression system (Djordjevic et al., 2005). This motif permits entry 
of nascent Plb into the endoplasmic reticulum (ER) where it is 
folded and acquires asparagines (N)-linked glycosylation which 
in the case of CnPlb1 is essential for activity (Chen et al., 2000) 
and export and secretion (Turner et al., 2006). The Plbs are then 
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optimum of between 3.0 and 3.5 (Farkas et al., 2009). As station-
ary phase is also the time when CnPlb1 secretion is optimal, it is 
tempting to speculate that extracellular β-glucanases can release 
cell wall proteins, such as CnPlb1, into the external environment, 
while simultaneously making cell wall sugar available to nutrient-
depleted cells in stationary phase. Six endo β-1,3-glucanase iso-
forms have been extracted from cryptococcal cell walls (Macekova 
et al., 2006). The C. neoformans genome encodes a family of four 
putative β-1-3-glucanases which could be involved in the release of 
CnPlb1. Cleavage of β-1,3-glucans, which in yeast are attached to 
β-1,6-glucans (Aimanianda et al., 2009), would result in the release 
of β-1-6-glucans and their attached proteins. Using gene deletion 
analysis, our laboratory is investigating the role of β-1-3-glucanases 
in CnPlb1 cell wall retention and secretion.
In addition to CnPlb1, the externalization of two other viru-
lence determinants, laccase (Lac 1) and capsular glucuronoxy-
lomannan (GXM), is dependent on fungal secretion pathways. 
Recent studies in C. neoformans defined separate pathways for 
export of Lac1 and GXM, which utilize SEC6-dependent exosomes 
of the lysosomal trafficking pathway and SAV1(SEC4)-dependent 
vesicles, respectively (Yoneda and Doering, 2006; Panepinto et al., 
2009). Recently we determined that CnPlb1 cellular export and 
secretion in C. neoformans, but not that of Lac1 and GXM, is 
dependent on a gene homologs to SEC14 from S. cerevisiae, which 
encodes a PI-transfer protein (PITP). This finding provides further 
support for the existence of distinct cellular pathways for export 
of virulence determinants in C. neoformans (unpublished data). 
Recently, several cryptococcal virulence determinants including 
laccase, urease, and soluble GXM polysaccharide, but not CnPlb1 
to a significant extent, were shown to be transported across the 
cryptococcal cell wall to the external milieu via SEC6-dependent 
exosomes (Rodrigues et al., 2007, 2008; Casadevall et al., 2009; 
Panepinto et al., 2009). The mechanism of release of these  virulence 
determinants from exosomes is unknown, but might involve the 
membrane hydrolytic action of cell wall-associated phospholipases 
such as CnPlb1.
role of plb1 in pathogenesis
The relative importance of the three phospholipase B activities 
(PLB, LPL, and LPTA) in fungal pathogenesis may vary in the dif-
ferent host microenvironments. It has been shown that the LPL 
and LPTA activities of CnPlb1 can reacylate lysophospholipids and 
reverse the damage caused to neutrophils by other secreted crypto-
coccal components (Santangelo et al., 1999). The roles of the vari-
ous activities in pathogenesis is discussed in more detail below.
host adhesion/penetration and dissemination
Plb enzymes are proven fungal invasions in C. albicans and C. 
neoformans. The first barriers encountered by infectious C. neo-
formans propagules are lung surfactant and lung epithelial cells. 
DPPC and PG, which are abundant in lung surfactant and dioleoyl 
PC (DOPC), which is present in the outer leaflet of mammalian 
cell membranes, are preferred substrates of CnPlb1 (Chen et al., 
1997a, 2000). Hydrolysis of these phospholipids by CnPlb1 would 
potentially facilitate penetration of host tissue and establishment of 
cryptococcal infection. In support of this, partially purified CnPlb1 
hydrolyses lung surfactant (Santangelo et al., 1999) and facilitates 
2005). However despite this, absence of a GPI anchor resulted in 
a greater than 50% reduction in the rate of CnPlb1 export and 
secretion, consistent with export of truncated protein being less 
efficient than that of native CnPlb1 (Djordjevic et al., 2005). Thus, 
the acquisition of the GPI anchor in CnPlb1 serves to expedite 
CnPlb1 transport through the secretory pathway, and to localize 
CnPlb1 at the fungal cell periphery.
N-linked Glycosylation. Using site-directed mutagenesis, we also 
showed that altering just a single N-linked glycosylation site out 
of the potential 17 that exist in CnPlb1, caused a retardation in 
cellular export and secretion of CnPlb1 within the heterologous 
host, S. cerevisiae, irrespective of GPI anchor status, consistent with 
N-linked glycosylation being more crucial for CnPlb1 traffic than 
acquisition of the GPI anchor. Specifically, CnPlb1 export and 
secretion was compromised when three individual glycosylation 
sites, Asn56, Asn430, and Asn550, were changed to Ala (Turner 
et al., 2006).
Surface-release mechanisms. Following CnPlb1 export to raft 
membranes, some CnPlb1 is relocated to the cell wall and/or is 
secreted, though the mechanism of release is not known (Siafakas 
et al., 2006, 2007). The membrane GPI anchor is a potential sub-
strate for (G)PI-PLC, (G)PI-PLD (de Almeida and Heise, 1993; 
Kristiansen and Richter, 2002) and/or a number of different pro-
teases (Muller et al., 1996; Parkin et al., 2004; Gagnon-Arsenault 
et al., 2008) and/or α-mannosidase (Fujii et al., 1999; Kitagaki et al., 
2002). We recently showed that secretion of CnPlb1 is dependent 
on PLC1 which encodes a PI-PLC (Chayakulkeeree et al., 2008). 
However the mechanism by which PLC1 achieves this is unclear 
(discussed in more detail below). Cell wall CnPlb1 associates with 
β-1,6-glucan (Siafakas et al., 2007) which, in C. neoformans, is much 
more abundant than β-1,3-glucan relative to other yeasts (Doering, 
2009). β-1,6-glucans are also associated with secreted CnPlb1, sug-
gesting that secreted CnPlb1 is derived from the cell wall reservoir 
(Siafakas et al., 2007). Disruption of specific KRE family genes in 
C. neoformans (KRE5 and KRE6/SKN1), which in S. cerevisiae are 
required for synthesis of β-1,6-glucan, caused a reduction in the 
β-1,6-glucan content of the cell wall (Gilbert et al., 2010). This 
reduction in β-1,6-glucan coincided with compromised cell wall 
integrity and reduced retention of CnPlb1 in the cell wall (Gilbert 
et al., 2010) supporting the previous finding that CnPlb1 is retained 
in the cell wall via a linkage to β-1,6-glucan (Siafakas et al., 2007). 
That β-1,6-glucans are retained on secreted CnPlb1 suggests that 
extracellular endo β-glucanases may be involved in the release of 
CnPlb1 from the cell wall, in addition to fulfilling a traditional role 
in cell wall remodeling.
Extracellular glucanase activity, including α-mannosidase, 
α- and β-glucosidase, α- and β-galactosidase, β-xylosidase, 
β-glucuronidase, and endo β-1,3-glucanase is associated with the 
capsule and/or the cell wall of C. neoformans and some of the sub-
strates of these enzymes can support yeast growth (Macekova et al., 
2006). Synthesis of the majority of these enzymes is regulated by 
glucose repression (Macekova et al., 2006). It has been demon-
strated that many cells die as they enter stationary phase due to 
erosion of their cell walls by autolysis, and that this coincides with 
an increase in externalization of β-1,3-glucanase activity with a pH 
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Although the role of secreted CaPlb1 in adhesion of C. albicans 
to host epithelium is not well-established, there is evidence that 
CaPlb1 does play a role in damage to, and penetration of, host 
epithelium, as culture supernatants from wild-type C. albicans 
caused twice as much damage to epithelial cells as those from a 
CaPLB1-deficient strain (Ghannoum, 2000). Furthermore, CaPlb1 
activity is concentrated at the growing tip of the invading hyphae 
(Mukherjee et al., 2001).
immunomodulation
CnPlb1 is essential for the synthesis of bioactive anti-inflammatory 
eicosanoids by C. neoformans, both in vitro and in vivo (Noverr 
et al., 2002, 2003), and therefore has the potential to suppress the 
host immune system, promoting the survival, and dissemination 
of C. neoformans within the host. Arachidonic acid (AA) is the pre-
cursor of eicosanoids. C. neoformans lacks arachidonic acid (AA), 
but readily takes it up in vitro (Wright et al., 2007). Furthermore 
during phagocytosis, macrophage-derived AA can be incorporate 
into cryptococcal lipids by a process that is dependent on the LPTA 
activity of CnPlb1 (Wright et al., 2007). CnPlb1 is also essential 
for the synthesis of eicosanoids derived from diarachidonyl PC 
(Noverr et al., 2003). However, Wright et al. (2007) found evidence 
to suggest that free AA generated by the host, presumably by cPLA
2
, 
is the substrate for CnPlb1-dependent eicosanoid production in 
C. neoformans, as neither wild type nor Cn∆plb1 could release 
AA from the sn-2 position of the more physiologically relevant 
phospholipid, palmitoylarachidyl PC (PAPC). In C. albicans, the 
PLA
2
 activity of CaPlb5 can release AA from PAPC (Theiss et al., 
2006). This is consistent with one role for CaPlb5 in pathogenesis, 
being to generate bioactive lipid mediators, such as AA, from host 
membranes. This AA potentially provides precursors for pro- or 
anti-inflammatory compounds including eicosanoids (Theiss et al., 
2006). This process may also coincide with the breakdown of host 
cell membranes leading to cell lysis.
fungal nutrition, membrane remodeling, signaling and cell 
wall integrity
Cryptococcus neoformans can utilize both phospholipids and fatty 
acids as a sole carbon source, and CnPlb1 is required for the uptake 
and esterification of fatty acids during stress (Wright et al., 2007). 
Thus during infection, CnPlb1-dependent hydrolysis of phospholi-
pids in host membranes could provide an energy source and confer 
a survival advantage on C. neoformans within the low glucose envi-
ronments of the macrophage phagolysosome and cryptococcomas, 
particularly as CnPlb1 enzymatic activity is energy-independent 
(Wright et al., 2007). Consistent with this hypothesis, Cn(∆plb1 
has a slower rate of intracellular growth than the wild-type strain 
at early time points post-phagocytosis (Cox et al., 2001). Wright 
et al. (2007) also demonstrated CnPlb1-dependence of metabo-
lism of the physiologically relevant lipids, DPPC and DOPC, and 
the cellulolytic compound lysoPC under stress conditions, and of 
detoxification of lysoPC by LPTA.
The CnPlb1-derived product of phosophatidylcholine, GPC, 
which is produced within cryptococcomas, in vivo, could be derived 
from either the yeast or the host. However we have reported that GPC 
is present in supernatants of cryptococci cultured in vitro (Bubb et al., 
1999). As the secretion medium lacked phospholipid and CnPlb1 is 
adherence of cryptococci to lung epithelial cells (Ganendren et al., 
2006). CnPlb1 also facilitated the entry of endotracheally adminis-
tered cryptococci into lung interstitial macrophages although the 
mechanism of traversal across the lung epithelial barrier remains 
unknown. The reduced lung burdens of cryptococci observed 
after infection with the CnPlb1 deletion mutant (∆plb1) may be 
explained by decreased invasive potential; it is also possible that 
multiplication within the host is inhibited. CnPlb1 is also essential 
for dissemination of C. neoformans from the lung to the brain via 
the blood, and possibly, the lymphatic system (Cox et al., 2001; 
Noverr et al., 2003; Santangelo et al., 2004). However, CnPlb1 
is not essential for the establishment of neurological infections 
(Santangelo et al., 2004).
Cryptococcus neoformans is a facultative intracellular pathogen 
that survives and replicates within the intracellular phagolyso-
some of macrophages. Yeast–macrophage interactions result in 
several outcomes which potentially drive the establishment, pro-
gression, and dissemination of infection. Using a non-activated 
murine alveolar macrophage (AM) cell line, MHS-1, Noverr et al. 
(2003) showed that CnPlb1 is required for C. neoformans survival 
in the presence of these macrophages. Cox et al. (2001) showed 
that CnPlb1 promotes cryptococcal budding at early time points 
(1–3.5 h) post-phagocytosis by an activated J774 macrophage 
cell line. In contrast, phagocytosis of strain H99 (7.3% ± 1.2) 
by the phorbol-12-myristate 13-acetate-activated human mac-
rophage-like cell line, THP-1, was significantly greater than that 
of Cn∆plb1 (4.3% ± 0.8) (Wright et al., 2007). Not only does 
CnPlb1 facilitate entry of cryptococci into interstitial macro-
phages in the lung, but as demonstrated by Santangelo et al. 
(2004), it is also required for dissemination from the lungs to 
regional lymph nodes where cryptococci were observed to mul-
tiply within Langerhans-type giant cells (Santangelo et al., 2004). 
Higher brain burdens were observed following intravenous injec-
tion of lung macrophages infected with cryptococci compared 
with free cryptococci. Since the brain burden was independent 
of CnPlb1 it was concluded by the authors that macrophages 
provide a vehicle for dissemination of cryptococci to the brain 
(Santangelo et al., 2004). Further support for this was provided 
by Charlier et al. (2009).
CnPlb1 may also be required for cryptococci to exit macro-
phages and thereby avoid killing by macrophage immune defense 
mechanisms. Escape can occur either by macrophage lysis and cell 
death, or by non-lytic extrusion via a process that does not affect the 
viability of either C. neoformans or the host macrophage (vomocy-
tosis) (Alvarez and Casadevall, 2006, 2007; Ma et al., 2006, 2007). 
The acidic environment of macrophage phagolysosomes provides 
an optimal environment for CnPlb1 catalytic activity. Feldmesser 
et al. (2000) reported disruptions in the phagolysosomal membrane 
of engulfed cryptococci which they attributed to secreted CnPlb1 
and/or proteases. Such membrane disruptions may allow lysis-
associated egress of C. neoformans from macrophages. Secreted 
CnPlb1 was recently found to facilitate non-lytic extrusion of C. 
neoformans from macrophages; two CnPlb1 strains defective in 
CnPlb1 secretion, due to CnPLB1 deletion or deletion of a secretory 
factor required for normal secretion of CnPlb1, exhibited reduced 
rates of vomocytosis, and failure to disseminate to the brain in a 
mouse model (manuscript submitted).
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explanation for why cPLA
2
 has a preference for AA in the sn-2 
position and removes only this fatty acid (Dessen, 2000), whereas 
CnPlb1 prefers either palmitoyl or oleoyl fatty acid in both the 
sn-1 and sn-2 positions and can remove both via the PLB activity 
(Chen et al., 2000) but cannot remove AA from the sn-2 position 
(Wright et al., 2007).
Sequence hypervariability was also identified in the binding 
tracts of the CnPlb1 active site providing a potential explanation 
for why various inhibitors differentially affect the three CnPlb1 
enzyme activities. This could occur if the different inhibitors exhib-
ited a preference for interaction with one binding tract over another. 
Alternatively, the initial point of contact of the substrate with the 
enzyme may not be the active site and may differ for phospholip-
ids and lysophospholipids. Molecular modeling also revealed the 




occludes the active site and is involved in interfacial activation. 
However, since CnPlb1 also displays interfacial activation in the 
absence of a lid, an alternative explanation is that this region is 
involved in substrate specificity, consistent with hypervariability in 
this region among cPLA
2
 isoforms and between cPLA
2
 and CnPlb1. 
Hence the lid region may function to recognize the appropriate 
lipid substrate in a membrane.
fungal plbs as antifungal drug targets
In light of the paucity of antifungal drug classes, the increasing 
incidence of relapsing invasive fungal infections and primary 
drug resistance, and unfavorable toxicity/bioavailability profiles 
of currently marketed antifungals, investigation of alternative 
compounds as stand-alone or synergistic therapies, is urgently 
needed. Fungal Plb and/or its biosynthetic pathway are novel 
targets for drug development and compounds with structural 
similarities to LysoPC, which is a preferred substrate of CnPlb1, 
have already been assessed for their antifungal effect. For many, 
there was a correlation between antifungal and anti-CnPlb1 
 activity but not all demonstrated selectivity for CnPlb1 compared 
with mammalian phospholipase, and some were toxic to mam-
malian cells.
Early studies using four commercially available compounds 
[alexidine dihydrochloride (compound A), dioctadecyldimethylam-
monium bromide (compound O), 1,12 bis-(tributylphosphonium)-
dodecane dibromide (compound P), and decamethonium 
dibromide (compound D)], showed both selectivity for CnPlb1 and 
antifungal activity. The best CnPlb1 inhibitors (compounds A and 
P) displayed the most potent antifungal activity. Compound A was 
highly selective for secreted and cell-associated PLB activities and 
showed no inhibition of mammalian PLA
2
. Compound O, which 
was specific for secretory and cytosolic LPL and LPTA activities and 
membrane-associated PLB activity, was not antifungal (Ganendren 
et al., 2004). Non-specific detergent-like action of the compounds 
was ruled out by the fact that they exhibited a selective inhibitory 
effect on the different enzyme activities.
These initial observations prompted us to synthesize and test 
three classes of compound with structural similarities to lysoPC, 
as potential antifungal agents. Alkyl-bis(phosphonium) analogs of 
these were active against yeasts and filamentous fungi including A. 
fumigatus, A. terreus, and Scedosporium apiospermum, with MICs 
similar to those of Amphotericin B (Obando et al., 2007). Although 
the only enzyme with PLB activity secreted under these conditions, 
the GPC must have been derived from cryptococcal lipid by the 
hydrolytic action of CnPlb1. Localization of CnPlb1 in the outer 
leaflet of membranes with lipid raft-like properties, provides cir-
cumstantial evidence for a role within membranes (Siafakas et al., 
2006). Interestingly however, PLB activity is, in fact, suppressed in 
the raft environment (Siafakas et al., 2006) suggesting that sequestra-
tion of CnPlb1 in lipid rafts may be a mechanism to prevent fungal 
membrane damage and/or regulate lipid remodeling within the outer 
membrane leaflet. Presumably any membrane homeostatic effect of 
CnPlb1 would occur only after release from the GPI anchor. Although 
lipid rafts generally facilitate signal activation, there is precedent for 
suppression of enzyme activity within the raft environment, in this 
case for a metalloproteinase (Kim and Chung, 2008).
It is also plausible that CnPlb1 is involved in fungal cell signaling 
following hydrolysis of the GPI anchor, which simultaneously releases 
CnPlb1 from raft membranes and generates the signaling molecule, 
diacylglycerol (DAG). In support of this, GPI anchored proteins are 
thought to be involved in signal transduction in mammalian cells 
(Stulnig et al., 1997). CnPlb1 could also regulate lysophosphatidic 
acid (LPA) levels which, in mammalian cells, are associated with 
regulation of PKC (Holmstrom et al., 2010). CnPlb1 also contributes 
to cell wall integrity (Chayakulkeeree et al., 2008), either by the physi-
cal nature of its GPI-anchored status in the cell wall, by maintaining 
the integrity of the membrane to which the cell wall is fixed or via a 
role in cell wall-related signal transduction involving PKC. In fungi, 
PKC is an enzyme within the PKC/Mpk1 cell wall integrity pathway, 
but is also a central regulator of signal transduction pathways that 
impacts on host cell physiology (Gerik et al., 2008).
molecular modeling and site-directed mutagenesis 
reveal a single active site in cnplb1
Previous studies demonstrated that several agents, including a 
CnPlb1 peptide-directed antibody, differentially inhibit either 
the LPL/LPTA, or the PLB activities of secreted CnPlb1 (Chen 
et al., 2000; Ganendren et al., 2004), suggesting that CnPlb1 has 
more than one active site. However, site-directed mutagenesis 
and molecular modeling in CnPlb1 (Jones et al., 2007) based on 
the X-ray crystal structure of the catalytic domain of mamma-




) (Dessen, 2000), revealed 
that CnPlb1 has only a single active site consisting of the same 
catalytic residues (S146, D392, and R108) as those involved in 
catalysis of nearly all fungal Plbs (Pickard et al., 1996) and human 
cPLA
2 
(S228, D549, and R200) (Jones et al., 2007). Comparison 
of the CnPlb1 molecular model and the cPLA
2
 crystal structure 
revealed the presence of a hydrophobic binding pocket, which 
accommodated the catalytic residues in identical positions, with 
S/D forming a catalytic dyad (Jones et al., 2007). In both struc-
tures, R108/R200 is sufficiently distanced from the S/D catalytic 
dyad to stabilize binding of the phospholipid head group and 
to allow cleavage of the acyl chain of the substrate, by the cata-
lytic dyad (Jones et al., 2007). In silico substrate docking studies 
revealed that each phospholipid acyl chain is accommodated by 
an upper and a lower hydrophobic binding tract and that fatty 
acyl cleavage at the sn-2 ester bond occurs within the upper 
binding tract. Sequence hypervariability was identified in the 
CnPlb1 and cPLA
2
 upper binding tracts, providing a potential 
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differences, combined with the fact that deletion of fungal PLC1 
genes leads to severely compromised growth phenotypes (Flick and 
Thorner, 1993; Payne and Fitzgerald-Hayes, 1993; Yoko-o et al., 1993; 
Chayakulkeeree et al., 2008), or lethality in the case of C. albicans 
(Kunze et al., 2005), highlights the potential of Plc enzymes as anti-
fungal drug targets. In contrast to C. neoformans and C. albicans, 
ScPLC1 is the sole Plc in S. cerevisiae.
CnPLC2 encodes a 430 amino acid protein which contains an 
X catalytic domain but no C2 domain. It is therefore more similar 
to prokaryotic PI-PLCs, many of which are proven pathogenicity 
determinants (Poussin and Goldfine, 2005; Poussin et al., 2009). 
Although not essential for pathogenicity in C. neoformans, CnPlc2 
may provide some functional redundancy as deletion of CnPLC1 
is not lethal (Chayakulkeeree et al., 2008). In contrast, deletion of 
CaPLC1 is lethal in C. albicans, despite the presence of two prokary-
ote-like Plc-encoding genes, CaPLC2 and CaPLC3, which therefore 
cannot functionally compensate for loss of CaPLC1 (Kunze et al., 
2005). CaPlc2 and CaPlc3 both share homology to PlcA (a PI-PLC), 
which is a known virulence factor of the human pathogen, Listeria 
monocytogenes (Wei et al., 2005). However in contrast to L. mono-
cytogenes, CaPlc2 and CaPlc3 are dispensable for virulence and 
yeast–macrophage interactions. Additionally, they are not required 
for yeast–hyphal switching, despite augmented mRNA expression 
under hypha-inducing conditions (Knechtle et al., 2005). The func-
tion of CnPlc2, CaPlc2, and CaPlc3 remains to be elucidated.
plc – role in fungal pathogenicity
Plcs hydrolyse the membrane-proximal phosphoester bond of the 
phosphoryl head group of PI phospholipids and/or their phos-
phorylated and glycosylated derivatives [PI(4)P/PI(4,5)P/PIP2 and 
(G)PI, respectively]. The eukaryote-type enzymes prefer PIP
2
 as a 
substrate, over PI, while the prokaryote types prefer PI. Plcs from 
bacteria and some protozoan parasites are more efficient at cleaving 
GPI anchors and are therefore sometimes referred to as (G)PI-PLCs 
(Heinz et al., 1998). The release of CnPlb1 from membranes in C. 
neoformans, which allows its translocation to the cell wall and/or the 
extracellular environment, may be instigated by (G)PI-PLC activity. 
Surprisingly though, deletion of the more prokaryote-like CnPLC2 
in C. neoformans, did not alter CnPlb1 secretion and was dispen-
sable for phenotypic expression of pathogenic traits and virulence 
in an animal model (Chayakulkeeree et al., 2008), consistent with 
any potential CnPlc2 functionality being fully compensated for by 
CnPlc1. In contrast, deletion of the more eukaryote-like CnPLC1 
(Cn∆plc1), abrogated Plb1 secretion in broth cultures of C. neo-
formans (Chayakulkeeree et al., 2008). As CnPlc1 is not predicted 
to be secreted, and would therefore not have access to extracellular 
GPI anchors, the CnPlb1 secretion block in Cn∆plc1 should not be 
due to compromised GPI anchor cleavage in Cn∆plc1. Attempts to 
make a CnPLC1/PLC2 double deletion mutant were unsuccessful 
suggesting that loss of these two genes is lethal and that CnPlc2 is 
functional even though it cannot fully compensate for the loss of 
CnPlc1 (Chayakulkeeree et al., 2008).
CnPLC1 is essential for a number of other key survival and 
pathogenic determinants, including the ability of C. neoform-
ans to grow at physiological temperature; which predictably 
leads to avirulence of Cn∆plc1 in a mouse infection model 
(Chayakulkeeree et al., 2008). Even in a Caenorhabditis elegans 
promising, the selectivity of these prototype compounds for CnPlb1 
was unsatisfactory In contrast, the most promising compound of a 
novel structural class of bis-pyridinium compounds, was selectively 
active against CnPlb1, non-toxic to human erythrocytes and nucle-
ated mammalian cells and exhibited broad-spectrum antifungal 
activity (Obando et al., 2009). This compound is currently being 
tested for toxicity in animals.
Our search for compounds with substrate similarities to 
phospholipids yielded an additional candidate drug, miltefosine 
(hexadecylphosphocholine), which has been marketed as an oral 
formulation for the treatment of leishmaniasis. Miltefosine is a 
metabolically stable lysophospholipid analog which we reported to 
have broad-spectrum fungicidal activity in vitro against yeasts and 
molds, including resistant species such as Candida krusei, C. gla-
brata, S. prolificans, Fusarium species, and Zygomycetes (Widmer 
et al., 2006). MICs are well below serum levels achieved by oral 
dosing with miltefosine and there is very preliminary evidence of 
an effect in a mouse model of cryptococcosis and as combina-
tion salvage therapy in a child with severe, non-responsive, S. pro-
lificans infection (Kesson et al., 2009). Because of its undesirable 
gastrointestinal side-effects, the antifungal mode(s) of action of 
miltefosine are under investigation as a prelude to the development 
of more potent, less toxic analogs. To date, we have established 
that miltefosine does inhibit CnPlb1, but only at high concentra-
tions, suggesting that this is not its major mode of action (Widmer 
et al., 2006). Analogs of miltefosine have been synthesized and are 
under investigation.
In conclusion, although the mature CnPlb1 enzyme is a poten-
tial target for antifungal drug development, inhibitor compounds 
investigated so far appear to exert their antifungal effect through 
additional pathways. An alternative approach under active inves-
tigation is to seek to inhibit cellular synthesis and/or secretion of 
CnPlb1 (Siafakas et al., 2007).
role of fungal phospholipase c enzymes in fungal 
fitness and pathogenicity
how fungal plcs differ from the mammalian homologs
The C. neoformans genome contains two genes, PLC1 and PLC2, 
encoding putative phospholipase C enzymes (Chayakulkeeree et al., 
2008). CnPLC1 encodes a protein that is predicted to be 609 amino 
acids (CnPlc1), with X and Y catalytic domains that are characteristic 
of eukaryotic Plcs, including the homologs from C. albicans (CaP1c1) 
(Kunze et al., 2005) and S. cerevisiae (ScPlc1) (Flick and Thorner, 
1993; Yoko-o et al., 1993). Like CaP1c1 and ScPlc1, CnPlc1 contains 
a C2 domain which is predicted to bind Ca2+, and is 26% similar at 
the amino acid level to both proteins (Chayakulkeeree et al., 2008). 
In contrast to ScPlc1 and the mammalian Plc-δ homolog which is 
most similar (32%) to the fungal homologs, CnPlc1 and CaPlc1 
lack the EF hand regulatory domain suggesting differences in their 
mechanism of action. Furthermore, all of the fungal Plcs, lack the 
pleckstrin homology (PH) membrane binding domain which is 
present in mammalian Plc-δ. Other potentially significant differ-
ences between the fungal and mammalian enzymes include the 
presence of an unusually long N-terminal extension in the fungal 
enzymes (Flick and Thorner, 1993; Bennett et al., 1998), and obser-
vation that fungal enzymes are predicted to be basic while the rat 
and bovine enzymes are acidic (Flick and Thorner, 1993). These 
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cnpLC1 – a potential branch point enzyme for 
integrating virulence-related signal transduction
There are at least six signaling pathways in C. neoformans that regu-
late virulence (reviewed in Kozubowski et al., 2009). The CnPlc1-
dependent virulence phenotypes (melanin, capsule, high temperature 
growth, and cell wall integrity) are regulated by three of these: the 
cAMP/protein kinase A(Pka) pathway, Ca2+/Calcineurin pathway 
and the protein kinase C1 (Pkc1)/mitogen activated protein kinase 
1 (Mpk1) pathway. High temperature growth and cell wall integrity 
are regulated through the Ca2+/Calcineurin and Pkc1/Mpk1 pathway. 
There is also evidence of cross-talk between the Ca2+/calcineurin and 
the Pkc1/Mpk1 pathways to regulate cell wall integrity in C. neoform-
ans. Firstly, the mRNA of CnFKS1, which is a gene target of the Pkc1/
Mpk1 pathway, is upregulated by loss of calcineurin function (Kraus 
et al., 2003). Secondly, inhibition of calcineurin by FK506 induces 
CnFKS1 mRNA expression and activates CnMpk1 (Kraus et al., 2003). 
Finally, melanin, capsule, and mating are regulated through the cAMP/
Pka pathway (Alspaugh et al., 1997; Alspaugh et al., 2002). Whether 
production and/or secretion of the invasin, CnPlb1, is also regulated 
by one of these signaling pathways, is yet to be determined.
Hydrolysis of PIP
2
 and, to a lesser extent of PI, was reduced 
in Cn∆plc1 (Chayakulkeeree et al., 2008), providing evidence that 
CnPlc1 is a functional enzyme involved in signaling. Preferential 
hydrolysis of PIP
2
 over PI generates two intracellular secondary 
messengers, 1,2-diacylglycerol (DAG) (the sole hydrolysis product 
of PI) and inositol 1,4,5-trisphosphate (IP
3
) which can activate 
the Pkc1/Mpk1 and Ca2+/Calcineurin pathways, respectively. It has 
been shown that DAG generated by the sphingolipid biosynthetic 
pathway activates CnPkc1 to regulate cell wall integrity and mela-
nin production (Heung et al., 2005). Thus, CnPlc1-generated DAG 
could play a similar role. In support of this, Cn∆plc1 has a cell wall 
integrity defect and Mpk1 is not activated in Cn∆plc1 following cell 
wall perturbation (Chayakulkeeree et al., 2008). Thus, CnPlc1 can 
potentially integrate signaling through both the Pkc1/Mpk1 and 
Ca2+/Calcineurin pathways to regulate high temperature growth 
and cell wall integrity, and potentially, melanin production (see 
Figure 3). CnPlc1 signal transduction may be influenced by PI-3 
kinase, which is a potential competitor for PIP
2
 substrate and regu-
lator of melanization and autophagy virulence traits in C. neoform-
ans (Hu et al., 2008), and the phospholipid-binding protein, Cts1, 
which functions coordinately with calcineurin in C. neoformans to 
regulate growth and cell separation (Fox et al., 2003).
In S. cerevisiae, there is evidence that ScPlc1 signals through 
cAMP-regulated pathways. Firstly, ScPlc1 modulates interaction of 
the putative nutrient sensing G-protein coupled receptor, Gpr1p, 
with the Gα protein, Gpa2p, effecting cAMP-regulated filamenta-
tion (Ansari et al., 1999). Secondly, cAMP synthesis is decreased in 
Sc∆plc1 (Demczuk et al., 2008). In C. neoformans, a protein complex 
of Gpr4p, Gpa1p, and Crg2p, functions to control cAMP signaling 
via Pka (Kozubowski et al., 2009) to regulate melanin and cap-
sule production, and mating. Support for CnPlc1 being linked to 
this signaling pathway is that Cn∆plc1 has a melanin defect, as a 
result of reduced LAC1 mRNA transcription, and a capsule defect 
(Chayakulkeeree et al., 2008) and unpublished data, respectively (see 
Figure 3). A comparative transcriptomic study of a C. neoformans 
Pka catalytic subunit deletion mutant, and the WT, identified a role 
for the cAMP/Pka pathway in secretion and, in particular, secretion 
killing assay performed at the permissible growth temperature of 
28°C, Cn∆plc1 was less virulent than WT, demonstrating an effect 
not solely explained by the 37°C growth defect of this mutant 
(Chayakulkeeree et al., 2008). Furthermore, Cn∆plc1 could not 
make the stress-protecting pigment, melanin, due to suppression 
of transcription of the  laccase-encoding gene, LAC1, and dis-
played a cell morphology defect, compromised cell wall integrity 
and hypersusceptibility to clinically available antifungal drugs 
(Chayakulkeeree et al., 2008). Recently, we also demonstrated that 
capsules cannot be induced in Cn∆plc1 (Unpublished observa-
tion). Thus in contrast to C. albicans, C. neoformans can com-
pensate for loss of PLC1 at temperatures of ≤30°C. This is most 
likely achieved through functional adaptation by CnPlc2 which 
may account for the residual Plc activity in Cn∆plc1 cell lysates 
(Chayakulkeeree et al., 2008).
plc – role in other fungi
PLC1 orthologs in other fungi appear to have a similar function to 
CnPLC1. However, unlike in C. neoformans and S. cerevisae, CaPLC1 
is an essential gene, as attempts to disrupt both CaPLC1 alleles failed 
and disruption of the second allele was only possible in mutants 
with CaPLC1 gene duplication (Kunze et al., 2005). Furthermore, 
growth of C. albicans was blocked in the presence of the Plc-specific 
inhibitor, ET-18 (Kunze et al., 2005). A conditional CaPLC1 mutant 
had phenotypes similar to the PLC1 deletion mutant in S. cerevisiae 
(Flick and Thorner, 1993; Payne and Fitzgerald-Hayes, 1993) and 
C. neoformans (Chayakulkeeree et al., 2008), including sensitiv-
ity to osmotic stress, elevated temperature and growth on carbon 
sources other than glucose (Kunze et al., 2005). Additionally, this 
conditional mutant had defects in hyphal formation (Kunze et al., 
2005). Other defects apparent in the ScPLC1 deletion mutant are 
in morphology/budding and chromosome segregation (Payne and 
Fitzgerald-Hayes, 1993).
phospholipases – a role in non-fungal pathogens
Phospholipases are virulence determinants of bacteria and proto-
zoa, as well as fungi, and some examples are given below. Rickettsia 
rickettsii, the causative agent of life-threatening Rocky Mountain 
spotted fever, is an obligate intracellular bacterium. Phospholipase 
A
2
 is involved in rickettsial entry into host cells, escape from mac-
rophage phagosomes and host cell lysis (Silverman et al., 1992). 
Phospholipase A also facilitates dissemination from the host cell by 
two protozoan species, Toxoplasma gondii and Entamoeba histolytica 
(Ghannoum, 2000). Recently, a protein with phospholipase A activ-
ity was identified from R. typhi (Rahman et al., 2010).
PI-PLC from L. monocytogenes promotes escape of the bac-
terium from macrophage phagolysosmes via a mechanism that 
is dependent on host Pkcβ, which may be activated by PI-PLC-
generated DAG (Poussin and Goldfine, 2005; Poussin et al., 2009). 
The broad-range phospholipase C, PC-PLC, is also involved in 
vacuolar lysis by L. monocytogenes, allowing bacterial growth within 
the host cell cytosol, and spread from cell to cell via actin-based 
motility. Recently, it was shown that slowing the kinetics of vacuolar 
maturation in L. moncyotogenes creates an environment condu-
cive for PC-PLC-assisted vacuolar escape (Burrack et al., 2009). In 
another bacterium, Clostridium perfringens, Plc causes gas gangrene 
(Kennedy et al., 2009).
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understanding of signaling networks of pathogenic fungi, which can 
differ substantially from those of S. cerevisiae, and invites investiga-
tion of similar pathways in other pathogenic fungi.
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of capsular polysaccharide (Hu et al., 2007). However, secretion of 
protein-based virulence factors was not assessed. Further support for 
CnPlc1 being linked to the cAMP/Pka pathway in C. neoformans, is 
that CnPlb1 secretion is defective in Cn∆plc1 (Chayakulkeeree et al., 
2008). A comparison of secreted CnPlb1 in Pka mutants and WT 
is currently under investigation to determine whether this pathway 
does, in fact, play a role in controlling the secretion of pathogenicity 
determinants other than capsular polysaccharide.
In summary, CnPlc1 may represent an important branchpoint 
signaling enzyme and its relative contribution to individual signaling 
pathways will be determined through epistasis studies. These studies 
FIgure 3 | Proposed role of CnPlc1 in pathogenicity-related signaling in C. 
neoformans. 1. Cyclic AMP (cAMP)/Protein kinase A (Pka) signaling pathway. A 
change in extracellular nutrient levels trigger activation of the integral membrane-
associated G-protein coupled receptor, GPR4, causing its associated Gα subunit 
(Gpa1) to activate adenylyl cyclase (Cac1), resulting in production of cAMP. cAMP 
binds to regulatory subunits (Pkr1) of the Pka complex (not shown) to release an 
active form of the catalytic subunit (Pka1), which phosphorylates the transcription 
factor, Nrg1. A GTPase-activating protein (Crg2) negatively regulates Gpa1. Gib2, 
Gβ subunit. Based on studies in S. cerevisiae and our own published and 
preliminary data in C. neoformans demonstrating the requirement for CnPlc1 in 
melanin production (via LAC1 transcription), capsule production and secretion of 
virulence determinants (Chayakulkeeree et al., 2008), CnPlc1 may be linked to 
cAMP signaling possibly by regulating the activation of Gpa1 as indicated by the 
dashed line. Lac1, Laccase 1; GXM, glucuronic acid-xylose-mannan. 2. Ca2+/
calcineurin signaling pathway. This pathway primarily regulates high temperature 
growth in C. neoformans, but not in S. cerevisiae. High temperatures may trigger 
CnPlc1 to hydrolyse PIP2, producing IP3, which potentially raises intracellular Ca
2+ 
(see dashed line) by regulating Ca2+ pumps/channels in the plasma membrane 
and ER. Cytosolic Ca2+ is sensed by calmodulin (Cam1), which activates 
calmodulin kinases (CaMKs) (not shown) and the calcineurin complex (Cna1 and 
Cnb1) to support growth at 37°C. Cyclosporine A (CsA) and FK506, bind 
cyclophilin A and FKBP12, respectively, to inhibit calcineurin; PIP2, 
phosphatidylinositol 4,5-bisphosphate. Calcineurin is also essential for hyphal 
elongation during mating and monokaryotic fruiting (not shown). 3. Pkc1/Mpk1 
MAPK signaling pathway. This pathway conveys cell wall perturbation signals 
detected by unknown membrane sensors, to the nucleus. CnPlc1 is essential for 
activation of Mpk1 in response to cell wall perturbation in a process that may, or 
may not be, mediated by activation of Pkc1 via the CnPlc1 hydrolysis product, 
DAG (see dashed line). Activated Pkc1 phosphorylates MAPKKK (Bck1) and 
subsequent phosphorylations of MAPKK (Mkk2) by Bck1 and MAPK (Mpk1) by 
Mkk2 to upregulate transcription of FKS1, which encodes β-1,3-glucan synthase. 
Expression of FKS1 is also negatively regulated by calcineurin. DAG produced by 
the sphingolipid synthetic pathway enzyme inositolphosphoceramide 1 synthase 
(Ipc1), and possibly by CnPlc1, also activates CnPkc1 to regulate melanin 
production independently of Mpk1 activation (Heung et al., 2005). Pkc1 is also 
required for host temperature growth (Gerik et al., 2008).
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